Evidence map›Paper›PMID 21111048›Full record

ArticleProtein expression and purification2011

Expression, purification and analysis of the activity of enzymes from the pentose phosphate pathway.

Patrick K Arthur, Luigi J Alvarado, T Kwaku Dayie

Abstract read
In one paragraph

Article in Protein expression and purification, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Selective [9-Chembiochem : a European journal of chemical biology · 2025
    Article
  3. Article
  4. Review
  5. Synthesis of [7-Monatshefte fur chemie · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Patrick K ArthurCenter for Biomolecular Structure and Organization, University of Maryland, College Park, MD 20742-3360, USA.
Luigi J Alvarado
T Kwaku Dayie
University of Maryland, College Park · US

Funding

Structure of a ribozyme catalytic centerR01GM077326 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI DAYIE, KWAKU · 2007 to 2011
$1.4M
NIGMS NIH HHS R01 GM077326NIGMS NIH HHS R01 GM77326
6 · The paper itself

Abstract

RNAs, more than ever before, are increasingly viewed as biomolecules of the future, in the versatility of their functions and intricate three-dimensional folding. To effectively study them by nuclear magnetic resonance (NMR) spectroscopy, structural biologists need to tackle two critical challenges of spectral overcrowding and fast signal decay for large RNAs. Stable-isotope nucleotide labeling is one attractive solution to the overlap problem. Hence, developing effective methods for nucleotide labeling is highly desirable. In this work, we have developed a facile and streamlined source of recombinant enzymes from the pentose phosphate pathway for making such labeled nucleotides. The Escherichia coli (E. coli) genes encoding ribokinase (RK), adenine phosphoribosyltransferase (APRT), xanthine/guanine phosphoribosyltransferase (XGPRT), and uracil phosphoribosyltransferase (UPRT) were sub-cloned into pET15b vectors. All four constructs together with cytidine triphosphate synthetase (CTPS) and human phosphoribosyl pyrophosphate synthetase isoform 1 (PRPPS) were transformed into the E. coli BL21(AI) strain for protein over-expression. The enzyme preparations were purified to >90% homogeneity by a one-step Ni-NTA affinity chromatography, without the need of a further size-exclusion chromatography step. We obtained yields of 1530, 22, 482, 3120, 2120 and 2280 units of activity per liter of culture for RK, PRPPS, APRT, XGPRT, UPRT and CTPS, respectively; the specific activities were found to be 70, 22, 21, 128, 144 and 113 U/mg, respectively. These specific activities of these enzyme constructs are comparable to or higher than those previously reported. In addition, both the growth conditions and purification protocols have been streamlined so that all the recombinant proteins can be expressed, purified and characterized in at most 2 days. The availability and reliability of these constructs should make production of fully and site-specific labeled nucleotides for making labeled RNA accessible and straightforward, to facilitate high-resolution NMR spectroscopic and other biophysical studies.

Indexed as

Pentose Phosphate PathwayCarbon-Nitrogen LigasesChromatography, AffinityElectrophoresis, Polyacrylamide GelEscherichia coliHistidineHumansNickelNuclear Magnetic Resonance, BiomolecularPentosyltransferasesRecombinant Fusion ProteinsRibose-Phosphate PyrophosphokinaseCarbon-Nitrogen LigasesCTP synthetaseHistidineNickelPentosyltransferasesPRPS1 protein, humanRecombinant Fusion ProteinsRibose-Phosphate Pyrophosphokinase

Identifiers

PMID21111048
PMCPMC4125576
OpenAlexW2090715158

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.